Conservative management of chronic pancreatitis

Asian Journal of Surgery

Volumn 24, Issue 2, 2001, Pages 103-115

  Apte, M V ^a   Keogh, G W ^a   Wilson, J S ^a  

^a BANKSTOWN LIDCOMBE HOSPITAL   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

ANALGESIC AGENT; ANTIOXIDANT; COTAZYM S FORTE; HISTAMINE H2 RECEPTOR ANTAGONIST; INSULIN; KREON; PANCRELIPASE; PANZYTRAT; PROTON PUMP INHIBITOR; TRAMADOL; TRIACYLGLYCEROL LIPASE;

ABDOMINAL PAIN; BLOOD GLUCOSE MONITORING; CHRONIC PANCREATITIS; CONFERENCE PAPER; CONSERVATIVE TREATMENT; DIABETES MELLITUS; DIGESTIVE SYSTEM FUNCTION DISORDER; HUMAN; NUTRITIONAL SUPPORT; TREATMENT INDICATION; TREATMENT PLANNING;

EID: 0034896967     PISSN: 10159584     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Conference Paper

References (105)

1. Chronic pancreatitis
2. Chronic relapsing pancreatitis: A study of 29 cases without associated disease of the biliary or gastrointestinal tract
3. The morphological basis for the evolution of acute pancreatitis into chronic pancreatitis
4. Progression of alcoholic acute to chronic pancreatitis
5. Periacinar stellate-shaped cells in rat pancreas: Identification, isolation and culture
6. Pancreatic stellate cells are activated by proinflammatory cytokines: Implications for pancreatic fibrogenesis
7. Activation of pancreatic stellate cells in human and experimental pancreatic fibrosis
8. Does alcohol directly stimulate pancreatic fibrogenesis? Studies with rat pancreatic stellate cells
9. Course and outcome of chronic pancreatitis. Longitudinal study of a mixed medical-surgical series of 245 patients
10. Feedback regulation of human pancreatic secretion. Effects of protease inhibition on duodenal delivery and small intestinal transit of pancreatic enzymes
11. Natural course in chronic pancreatitis. Pain, exocrine and endocrine pancreatic insufficiency and prognosis of the disease
12. The course of pain is the same in alcohol- and nonalcohol-induced chronic pancreatitis
13. Prognosis of chronic pancreatitis: An international multicenter study
14. Chronic pancreatitis
15. Death due to acute pancreatitis
16. The different courses of early- and late-onset idiopathic and alcoholic chronic pancreatitis
17. Follow-up study of chronic pancreatitis
18. Reversibility of exocrine pancreatic failure in chronic pancreatitis
19. Clinical course and prognosis of chronic pancreatitis
20. Effect of cessation of alcohol use on the course of pancreatic dysfunction in alcoholic pancreatitis
21. Alcohol abuse and chronic pancreatitis
22. Mortality factors associated with chronic pancreatitis. Unidimensional and multidimensional analysis of a medicalsurgical series of 240 patients
23. Prognosis and prognostic factors in chronic pancreatitis
24. Pancreatic duct pressure in chronic pancreatitis
25. Pancreatic tissue fluid pressure in chronic pancreatitis. Relation to pain, morphology, and function
26. Pancreatic tissue and ductal pressures in chronic pancreatitis
27. Pathology of chronic pancreatitis and pancreatic pain
28. Analysis of nerves in chronic pancreatitis
29. Nerve growth factor and its high affinity receptor in chronic pancreatitis
30. Relations between pancreatic enzyme ouputs and malabsorption in severe pancreatic insufficiency
31. Relationship between alcoholism and pancreatic insufficiency
32. Steatorrhoea: You cannot trust your eyes when it comes to diagnosis
33. Fecal fat concentration in patients with steatorrhea
34. Colipase and lipase secretion in childhood-onset pancreatic insufficiency. Delineation of patients with steatorrhea secondary to relative colipase deficiency
35. Rapid method for the determination of fat in feces
36. The steatocrit: A simple method for estimating stool fat content in newborn infants
37. Clinical use of acid steatocrit
38. A rapid reliable procedure for the determination of total fecal lipids with observation of the lipids excreted by human subjects in normal and pathological states
39. Improved recovery of fatty acid through direct transesterification without prior extraction or purification
40. Separation and quantitation of fatty acids, sterols and bile acids in feces by gas chromatography as the butyl ester-acetate derivatives
41. NMR spectrometry. A new method for total stool fat quantification in chronic pancreatitis
42. Near-infrared spectrometry analysis of fat, neutral sterols, bile acids, and short-chain fatty acids in the feces of patients with pancreatic maldigestion and malabsorption
43. Triolein breath test: A sensitive and specific test for fat malabsorption
44. Islet cell neogenesis in the pancreas
45. Pathology of the pancreas in diabetes mellitus
46. The enteroinsular axis
47. Reversal of impaired GIP and insulin secretion in patients with pancreatogenic steatorrhea following enzyme substitution
48. Glucagon secretion in acute and chronic pancreatitis
49. Glucose counter-regulation in diabetes secondary to chronic pancreatitis
50. Diabetes mellitus secondary to chronic pancreatitis
51. Diabetic retinopathy in chronic pancreatitis
52. Alcohol-induced pancreatitis (AIP)
53. The prevalence and severity of microvascular complications in pancreatic diabetes and IDDM
54. AGA technical review: Treatment of pain in chronic pancreatitis
55. Opioid analgesics and antagonists
56. Effect of tramodol and morphine on pain and gastrointestinal motor function in patients with chronic pancreatitis
57. Effect of analgesic drugs on electromyographic activity of the gastroeintestinal tract and sphincter of Oddi and on biliary pressure
58. Pain relief by an opioid without depresion of respiration
59. Abuse potential and pharmacological comparison of tramadol and morphine
60. Treatment of pain in chronic pancreatitis by inhibition of pancreatic secretion with octreotide
61. Journal of Clinical Investigation
62. Trypsin suppression of pancreatic enzyme secretion. Differential effect on cholecystokinin release and the enteropancreatic reflex
63. Pain reduction by an oral pancreatic enzyme preparation in chronic pancreatitis
64. Protease-specific suppression of pancreatic exocrine secretion
65. Symptomatic effect of pancreatic enzyme therapy in patients with chronic pancreatitis
66. Creon (enteric coated pancreatin microspheres) for the treatment of pain in chronic pancreatitis: A doubleblind randomised placebocontrolled crossover study
67. Treatment of pain with pancreatic extracts in chronic pancreatitis: Results of a prospective placebo-controlled multicenter trial
68. No effect of longterm treatment with pancreatic extract on recurrent abdominal pain in patients with chronic pancreatitis
69. Does pancreatic enzyme supplementation reduce pain in patients with chronic pancreatitis: A meta-analysis
70. Enzymatic therapy in patients with chronic pancreatitis
71. Enzyme declaration
72. Chronic Pancreatitis. Pathogenesis and management
73. Does allopurinol reduce pain of chronic pancreatitis?
74. Antioxidant therapy for recurrent pancreatitis: Placebo-controlled trial
75. What is the dose of lipolytic activity that corrects human pancreatic steatorhoea?
76. Strictures of ascending colon in cystic fibrosis and high-strength pancreatic enzymes
77. Colonic strictures in cystic fibrosis
78. Pathogenesis of fibrosing colonopathy: The role of mathacrylic acid coplymer
79. Fate of orally ingested enzymes in pancreatic insufficiency. Comparison of two dosage schedules
80. Impaired acid neutralization in the duodenum in pancreatic insufficiency
81. Influence of exocrine pancreatic insufficiency on the intraluminal pH of the proximal small intestine
82. Pancreatic enzyme replacement: The effect of antacids or cimetidine
83. Cimetidine as an adjunct to oral enzymes in the treatment of malabsorption due to pancreatic insufficiency
84. Omeprazole enhances the efficacy of pancreatin (pancrease) in cystic fibrosis
85. Improvement of fecal fat excretion after addition of omeprazole to pancrease in cystic fibrosis is related to residual exocrine function of the pancreas
86. Effects of a protonpump inhibitor in cystic fibrosis
87. Comparative evaluation of the therapeutic efficacy of a pH-sensitive enteric coated pancreatic enzyme preparation with conventional pancreatic enzyme therapy in the treatment of exocrine pancreatic insufficiency
88. Placebo controlled trial of enteric coated pancreatin microsphere treatment in patients with unresectable cancer of the pancreatic head region
89. Comparative effects of antacids, cimetidine and enteric coating on the therapeutic response to oral enzymes in severe pancreatic insufficiency
90. Inactivation of human lipase by proteases
91. Therapeutic potential and clinical efficacy of acid-resistant fungal lipase in the treatment of pancreatic steatorrhoea due to cystic fibrosis
92. Crystallization and preliminary Xray study of a lipase from Pseudomonas glumae
93. Lipolytic activity of bacterial lipase survives better than that of porcine lipase in human gastric and duodenal content
94. Bacterial lipase and high-fat diets in canine exocrine pancreatic insufficiency: A new therapy of steatorrhea?
95. Effect of bacterial or porcine lipase with low- or high-fat diets on nutrient absorption in pancreatic insufficient dogs
96. Survival of human pancreatic enzymes during small bowel transit: Effect of nutrients, bile acids, and enzymes
97. Oral pancreatic enzyme therapy in the control of diabetes mellitus in tropical calculous pancreatitis
98. Effect of glucagon-like peptide 1(7-36)amide in insulin-treated patients with diabetes mellitus secondary to chronic pancreatitis
99. Nutritional support for the patient with pancreatico-biliary disease
100. Nutritional aspects of chronic pancreatitis
101. Vitamin B12 absorption and chronic pancreatic insufficiency
102. Effect of sodium bicarbonate and pancreatin on the absorption of vitamin B12 and fat in pancreatic insufficiency
103. Does malabsorption of vitamin B 12 occur in chronic pancreatitis?
104. Deficiency in antioxidant factors in patients with alcohol-related chronic pancreatitis